Альманах-2014: природжені вади серця
P. Kahr, G.-P. Diller


1. Agnoletti G, Bordese R, Gabbarini F. Closure of a large ductus arteriosus in a preterm infant using the ADO II AS device. Heart. 2012;98:1394.
2. Agus MS, Asaro LA, Steil GM, et al. Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial. Circulation. 2014;129:2297-2304.
3. Alonso-Gonzalez R, Borgia F, Diller GP, et al. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890.
4. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99:491-496.
5. Baba K, Kotani Y, Chetan D, et al. Hybrid versus Norwood strategies for single-ventricle palliation. Circulation. 2012;126 (Suppl. 1):S123-131.
6. Barst RJ, McGoon MD, Elliott CG, et al. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125:113-122.
7. Beaton A, Okello E, Lwabi P, et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012;125:3127-3132.
8. Bossers SS, Cibis M, Gijsen FJ, et al. Computational fluid dynamics in Fontan patients to evaluate power loss during simulated exercise. Heart. 2014;100:696-701.
9. Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation. 2014;130:273-282.
10. Brown KL, Sullivan ID. Prenatal detection for major congenital heart disease: a key process measure for congenital heart networks. Heart. 2014;100:359-360.
11. Cantinotti M, Assanta N, Murzi B, et al. Controversies in the definition and management of insignificant left-to-right shunts. Heart. 2014;100:200-205.
12. Chetan D, Kotani Y, Jacques F, et al. Surgical palliation strategy does not affect interstage ventricular dysfunction or atrioventricular valve regurgitation in children with hypoplastic left heart syndrome and variants. Circulation. 2013;128 (Suppl. 1):S205-212.
13. Coats L, O’Connor S, Wren C, et al. The single-ventricle patient population: a current and future concern a population-based study in the North of England. Heart. 2014;100:1348-1353.
14. Cordina R, O’Meagher S, Gould H, et al. Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart. 2013;99:1530-1534.
15. Cunnington C, Hampshaw SA, Mahadevan VS. Utility of real-time three-dimensional intracardiac echocardiography for patent foramen ovale closure. Heart. 2013;99:1789-1790.
16. Cuypers JA, Eindhoven JA, Slager MA, et al. The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 years. Eur Heart J. 2014;35:1666-1674.
17. Cuypers JA, Witsenburg M, van der Linde D, et al. Pulmonary stenosis: update on diagnosis and therapeutic options. Heart. 2013;99:339-347.
18. D’Udekem Y, Xu M.Y, Galati JC, et al. Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance. J Am Coll Cardiol. 2012;59:1178-1185.
19. Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart. 2012;98:1098-1104.
20. Diller GP, Alonso-Gonzalez R, Kempny A, et al. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart. 2012;98:736-742.
21. Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440-2446.
22. Douwes JM, Roofthooft MTR, Van Loon RLE, et al. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre. Heart. 2014;100:224-230.
23. Duerr GD, Breuer J, Schiller W. A new transventricular aproach for pulmonary valve implantation in a patient with severe valve disease after tetralogy-of-Fallot repair. Heart. 2013;99:1469-1470.
24. Edwards NC, Griffiths M, Steeds RP. Intra-cardiac echocardiography in mitral valve repair: a novel use of a complimentary imaging modality in a difficult scenario. Heart. 2013;99:1791-1792.
25. Ferraz Cavalcanti PE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3118 patients from 48 studies. J Am Coll Cardiol. 2013;62:2227-2243.
26. Frigiola A, Hughes M, Turner M, et al. Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement. Circulation. 2013;128:1861-1868.
27. Frommelt PC, Guey LT, Minich LL, et al. Does initial shunt type for the Norwood procedure affect echocardiographic measures of cardiac size and function during infancy? The Single Ventricle Reconstruction trial. Circulation. 2012;125:2630-2638.
28. Frontera A, Thomas G, Duncan E. Cardiac arrest in concomitant Wolff-Parkinson-White syndrome and early repolarisation: is pathway ablation enough? Heart. 2014;100:598-599.
29. Gardiner HM, Kovacevic A, van der Heijden LB, et al. Prenatal screening for major congenital heart disease: assessing performance by combining national cardiac audit with maternity data. Heart. 2014;100:375-382.
30. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013;128:1855-1857.
31. Gopalamurugan AB, Reinthaler M, Mullen MJ. Percutaneous valve-in-valve implantations: importance of knowing the effective internal diameter of bioprosthetic valves. Heart. 2013;99:1709-1710.
32. Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259.
33. John AS, Johnson JA, Khan M, et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014;64:54-62.
34. Kampman MA, Balci A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J. 2014;35:708-715.
35. Kempny A, Dimopoulos K, Alonso-Gonzalez R, et al. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. Int J Cardiol. 2013;168:4784-4789.
36. Kempny A, Dimopoulos K, Gatzoulis MA. Single-ventricle physiology in the UK: an ongoing challenge of growing numbers and of growing complexity of congenital heart disease. Heart. 2014;100:1315-1316.
37. Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life - single centre experience and review of published data. Eur Heart J. 2012;33:1386-1396.
38. Khairy P, Clair M, Fernandes SM, et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013;127:331-339.
39. Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012;98:1667-1673.
40. Kim JB, Yoo DG, Kim GS, et al. Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes. Heart. 2012;98:24-30.
41. Krieger EV, Stout K. Progress: the ROPAC multinational registry advances our understanding of an important outcome in pregnant women with heart disease. Heart. 2014;100:188-189.
42. Lauten A, Hoyme M, Figulla HR. Severe pulmonary regurgitation after tetralogy-of-Fallot repair: transcatheter treatment with the Edwards SAPIEN XT heart valve. Heart. 2012;98:623-624.
43. Lee SP, Kim HK, Kim KH, et al. Prevalence of significant tricuspid regurgitation in patients with successful percutaneous mitral valvuloplasty for mitral stenosis: results from 12 years’ follow-up of one centre prospective registry. Heart. 2013;99:91-97.
44. Lloyd DF, Cutler L, Tibby SM, et al. Analysis of preoperative condition and interstage mortality in Norwood and hybrid procedures for hypoplastic left heart syndrome using the Aristotle scoring system. Heart. 2014;100:775-780.
45. Lutaaya M, Rajagopal R, More RS. Giant unruptured Sinus of Valsalva aneurysm: an unusual cause of aortic regurgitation. Heart. 2013;99:972.
46. Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749-756.
47. McCrossan B, Morgan G, Grant B, et al. A randomised trial of a remote home support programme for infants with major congenital heart disease. Heart. 2012;98:1523-1528.
48. Miranda J.O, Callaghan N, Miller O, et al. Right aortic arch diagnosed antenatally: associations and outcome in 98 fetuses. Heart. 2014;100:54-59.
49. Moceri P, Dimopoulos K, Liodakis E, et al. Echocardiographic predictors of outcome in eisenmenger syndrome. Circulation. 2012;126:1461-1468.
50. Mocumbi AO, Falase AO. Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa. Heart. 2013;99:1481-1487.
51. Mocumbi AO, Sliwa K. Women’s cardiovascular health in Africa. Heart. 2012;98:450-455.
52. Mokhles MM, Charitos EI, Stierle U, et al. The fate of pulmonary conduits after the Ross procedure: longitudinal analysis of the German-Dutch Ross registry experience. Heart. 2013;99:1857-1866.
53. Mongeon FP, Gurvitz MZ, Broberg CS, et al. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013;127:172-179.
54. Morrison ML, Sands AJ, McCusker CG, et al. Exercise training improves activity in adolescents with congenital heart disease. Heart. 2013;99:1122-1128.
55. Newburger J.W, Sleeper L.A, Frommelt P.C, et al. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014;129:2013-2020.
56. O’Meagher S, Munoz PA, Alison JA, et al. Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart. 2012;98:1595-1599.
57. Opotowsky AR, Siddiqi OK, D’Souza B, et al. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012;98:145-151.
58. Orwat S, Diller GP. Risk stratification in adults with repaired Tetralogy of Fallot: the long journey from clinical parameters and surface ECG to in-depth assessment of myocardial mechanics, volume and pressure loading. Heart. 2014;100:185-187.
59. Pagel C, Crowe S, Brown K, et al. The benefits and risks of risk-adjustment in paediatric cardiac surgery. Heart. 2014;100:528-529.
60. Pagel C, Utley M, Crowe S, et al. Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart. 2013;99:1445-1450.
61. Pieper PG, Balci A, Aarnoudse JG, et al. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation. 2013;128:2478-2487.
62. Radke RM, Diller GP, Duck M, et al. Endothelial function in contemporary patients with repaired coarctation of aorta. Heart. 2014;100:1696-1701.
63. Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease — an evidence-based guideline. Nat Rev Cardiol. 2012;9:297-309.
64. Rider OJ, Bissell M, Myerson SG. Congenital aortopulmonary window;an unusual cause of breathlessness. Heart. 2013;99:1546.
65. Roberts K, Maguire G, Brown A, et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014;129:1953-1961.
66. Rogers LS, Glatz AC, Ravishankar C, et al. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol. 2012;60:1018-1025.
67. Roifman I, Therrien J, Ionescu-Ittu R, et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126:16-21.
68. Roos-Hesselink JW, Ruys TPE, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34:657-665.
69. Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart. 2014;100:231-238.
70. Schranz D. Hybrid approach in hypoplastic left heart syndrome. Heart. 2014;100:750-751.
71. Shafer KM, Garcia JA, Babb TG, et al. The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). J Am Coll Cardiol. 2012;60:2115-2121.
72. Shahian DM, Jacobs JP, Edwards FH, et al. The society of thoracic surgeons national database. Heart. 2013;99:1494-1501.
73. Siddiqui J, Brizard CP, Galati JC, et al. Surgical valvotomy and repair for neonatal and infant congenital aortic stenosis achieves better results than interventional catheterization. J Am Coll Cardiol. 2013;62:2134-2140.
74. Swartz MF, Sena A, Atallah-Yunes N, et al. Decreased incidence of supravalvar pulmonary stenosis after arterial switch operation. Circulation. 2012;126 (Suppl. 1):S118-122.
75. Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725-732.
76. Ubeda Tikkanen A, Opotowsky AR, Bhatt AB, et al. Physical activity is associated with improved aerobic exercise capacity over time in adults with congenital heart disease. Int J Cardiol. 2013;168:4685-4691.
77. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100:247-253.
78. Van der Bom T, Bouma BJ, Meijboom FJ, et al. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J. 2012;164:568-575.
79. Van der Bom T, Winter MM, Bouma BJ, et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322-330.
80. Van der Bom T, Winter MM, Groenink M, et al. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle. J Am Coll Cardiol. 2013;62:926-936.
81. Vettukattil JJ. Three dimensional echocardiography in congenital heart disease. Heart. 2012;98:79-88.
82. Westhoff-Bleck M, Schieffer B, Tegtbur U, et al. Aerobic training in adults after atrial switch procedure for transposition of the great arteries improves exercise capacity without impairing systemic right ventricular function. Int J Cardiol. 2013;170:24-29.
83. Wray J, Frigiola A, Bull C. Loss to specialist follow-up in congenital heart disease, out of sight, out of mind. Heart. 2013;99:485-490.
84. Wren C, O’Sullivan J. Loss to follow-up of adults with repaired congenital heart disease. Heart. 2013;99:440-441.
85. Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-1168.
86. Zhao QM, Ma XJ, Ge XL, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet. 2014;384:747-754.
87. Zijlstra WM, Douwes JM, Rosenzweig EB, et al. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. J Am Coll Cardiol. 2014;63:2159-2169.
88. Zomer AC, Ionescu-Ittu R, Vaartjes I, et al. Sex differences in hospital mortality in adults with congenital heart disease: the impact of reproductive health. J Am Coll Cardiol. 2013;62:58-67.
89. Zomer AC, Vaartjes I, van der Velde ET, et al. Heart failure admissions in adults with congenital heart disease, risk factors and prognosis. Int J Cardiol. 2013;168:2487-2493.
90. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart. 2013;99:1554-1561.


[PDF] [Зміст журналу]